{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:04:44Z","timestamp":1761541484671,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Health Labor Sciences Research Grant","award":["H29-ICT-Ippan-002"],"award-info":[{"award-number":["H29-ICT-Ippan-002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00066-018-1407-y","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T04:31:41Z","timestamp":1543984301000},"page":"412-419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Institutional patient accrual volume and the treatment quality of I\u2011125 prostate seed implantation in a\u00a0Japanese nationwide prospective cohort study","Institutionelle Behandlungsvolumen und Therapiequalit\u00e4t der I\u2011125-Seed-Implantation beim Prostatakarzinom in einer japanweiten prospektiven Kohortenstudie"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2090-881X","authenticated-orcid":false,"given":"Katsumasa","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saiji","family":"Ohga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsunori","family":"Yorozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takushi","family":"Dokiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,5]]},"reference":[{"key":"1407_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/bjs.4954","volume":"92","author":"S Killeen","year":"2005","unstructured":"Killeen S, O\u2019sullivan M, Coffey J et\u00a0al (2005) Provider volume and outcomes for oncological procedures. Br J Surg 92:389\u2013402","journal-title":"Br J Surg"},{"key":"1407_CR2","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1200\/JCO.2005.04.2622","volume":"24","author":"BR Konety","year":"2006","unstructured":"Konety BR, Allareddy V, Modak S et\u00a0al (2006) Mortality after major surgery for urologic cancers in specialized urology hospitals: are they any better? J\u00a0Clin Oncol 24:2006\u20132012","journal-title":"J Clin Oncol"},{"key":"1407_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.eururo.2007.10.070","volume":"54","author":"C Jeldres","year":"2008","unstructured":"Jeldres C, Suardi N, Saad F et\u00a0al (2008) High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer. Eur Urol 54:97\u2013106","journal-title":"Eur Urol"},{"key":"1407_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.brachy.2012.03.003","volume":"11","author":"D Taussky","year":"2012","unstructured":"Taussky D, Moumdjian C, Larouche R et\u00a0al (2012) Seed migration in prostate brachytherapy depends on experience and technique. Brachytherapy 11:452\u2013456","journal-title":"Brachytherapy"},{"key":"1407_CR5","first-page":"6907","volume":"20","author":"NA Bockholt","year":"2013","unstructured":"Bockholt NA, DeRoo EM, Nepple KG et\u00a0al (2013) First 100 cases at a\u00a0low volume prostate brachytherapy institution: learning curve and the importance of continuous quality improvement. Can J Urol 20:6907\u20136912","journal-title":"Can J Urol"},{"key":"1407_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brachy.2008.09.003","volume":"8","author":"CR Loiselle","year":"2009","unstructured":"Loiselle CR, Waheed M, Sylvester J et al (2009) Analysis of the Pro-Qura Database: Rectal dose, implant quality, and brachytherapist\u2019s experience. Brachytherapy 8:34\u201339","journal-title":"Brachytherapy"},{"key":"1407_CR7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/cas.12168","volume":"104","author":"K Nakamura","year":"2013","unstructured":"Nakamura K, Ohga S, Yorozu A et\u00a0al (2013) Diffusion pattern of low dose rate brachytherapy for prostate cancer in. Japan Cancer Sci 104:934\u2013936","journal-title":"Japan Cancer Sci"},{"key":"1407_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10147-014-0704-4","volume":"20","author":"S Saito","year":"2015","unstructured":"Saito S, Ito K, Yorozu A et al (2015) Nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS). Int J Clin Oncol 20:375\u2013385","journal-title":"Int J Clin Oncol"},{"key":"1407_CR9","doi-asserted-by":"crossref","unstructured":"Ohashi T, Yorozu A, Saito S et al (2015) Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in Japanese Men: Nationwide J\u2011POPS Multi-institutional Prospective Cohort Study. Int J Radiat Oncol Biol Phys 93:141\u2013149","DOI":"10.1016\/j.ijrobp.2015.05.014"},{"key":"1407_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0360-3016(99)00069-3","volume":"44","author":"S Nag","year":"1999","unstructured":"Nag S, Beyer D, Friedland J et\u00a0al (1999) American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 44:789\u2013799","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1407_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.juro.2008.09.034","volume":"181","author":"AB Chen","year":"2009","unstructured":"Chen AB, D\u2019Amico AV, Neville BA, Steyerberg EW, Earle CC (2009) Provider case volume and outcomes following prostate brachytherapy. J Urol 181(1):113\u2013118","journal-title":"J Urol"},{"key":"1407_CR12","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ijrobp.2009.03.031","volume":"76","author":"L Potters","year":"2010","unstructured":"Potters L, Roach M, Davis BJ et al (2010) Postoperative nomogram predicting the 9\u2011year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a\u00a0prognostic variable. Int J Radiat Oncol Biol Phys 76:1061\u20131065","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1407_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0360-3016(98)00006-6","volume":"41","author":"RG Stock","year":"1998","unstructured":"Stock RG, Stone NN, Tabert A et al (1998) A dose\u2013response study for I\u2011125 prostate implants. Int J Radiat Oncol Biol Phys 41:101\u2013108","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1407_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0360-3016(99)00067-X","volume":"44","author":"GS Merrick","year":"1999","unstructured":"Merrick GS, Butler WM, Dorsey AT et\u00a0al (1999) Potential role of various dosimetric quality indicators in prostate brachytherapy. Int J Radiat Oncol Biol Phys 44:717\u2013724","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1407_CR15","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1118\/1.4725173","volume":"39","author":"LG Marcu","year":"2012","unstructured":"Marcu LG, Lawson JM, Rutten T et al (2012) Quality indicators and technique for analyzing permanent I\u2011125 prostate seed implants: seven years postimplant dosimetry evaluation. Med Phys 39:4123\u20134131","journal-title":"Med Phys"},{"key":"1407_CR16","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.brachy.2016.09.001","volume":"15","author":"N Katayama","year":"2016","unstructured":"Katayama N, Yorozu A, Maruo S et al (2016) Predictive factors of rectal toxicity after permanent iodine-125 seed implantation: Prospective cohort study in 2339 patients. Brachytherapy 15:736\u2013745","journal-title":"Brachytherapy"},{"key":"1407_CR17","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.ijrobp.2008.05.022","volume":"73","author":"M Keyes","year":"2009","unstructured":"Keyes M, Miller S, Moravan V et al (2009) Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients. Int J Radiat Oncol Biol Phys 73:1023\u20131032","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1407_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.radonc.2007.07.002","volume":"84","author":"MJ Zelefsky","year":"2007","unstructured":"Zelefsky MJ, Yamada Y, Gil\u2019ad NC et al (2007) Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications. Radiother Oncol 84:185\u2013189","journal-title":"Radiother Oncol"},{"key":"1407_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.brachy.2011.05.007","volume":"11","author":"M Keyes","year":"2012","unstructured":"Keyes M, Spadinger I, Liu M et al (2012) Rectal toxicity and rectal dosimetry in low-dose-rate 125 I permanent prostate implants: A long-term study in 1006 patients. Brachytherapy 11:199\u2013208","journal-title":"Brachytherapy"},{"key":"1407_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.brachy.2008.12.001","volume":"8","author":"N Patil","year":"2009","unstructured":"Patil N, Crook J, Saibishkumar EP et\u00a0al (2009) The effect of obesity on rectal dosimetry after permanent prostate brachytherapy. Brachytherapy 8:218\u2013222","journal-title":"Brachytherapy"},{"key":"1407_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2007.01.014","volume":"83","author":"C Salembier","year":"2007","unstructured":"Salembier C, Lavagnini P, Nickers P et\u00a0al (2007) Tumour and target volumes in permanent prostate brachytherapy: a\u00a0supplement to the ESTRO\/EAU\/EORTC recommendations on prostate brachytherapy. Radiother Oncol 83:3\u201310","journal-title":"Radiother Oncol"},{"key":"1407_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.brachy.2015.12.011","volume":"15","author":"T Eriguchi","year":"2016","unstructured":"Eriguchi T, Yorozu A, Kuroiwa N et al (2016) Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy. Brachytherapy 15:288\u2013295","journal-title":"Brachytherapy"},{"key":"1407_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.radonc.2011.12.011","volume":"103","author":"M Pinkawa","year":"2012","unstructured":"Pinkawa M, Holy R, Piroth MD et\u00a0al (2012) Urinary morbidity after permanent prostate brachytherapy\u2013Impact of dose to the urethra vs. sources placed in close vicinity to the urethra. Radiother Oncol 103:247\u2013251","journal-title":"Radiother Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1407-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-018-1407-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1407-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T19:09:16Z","timestamp":1575486556000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-018-1407-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1407"],"URL":"https:\/\/doi.org\/10.1007\/s00066-018-1407-y","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"type":"print","value":"0179-7158"},{"type":"electronic","value":"1439-099X"}],"subject":[],"published":{"date-parts":[[2018,12,5]]},"assertion":[{"value":"29 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"K.\u00a0Nakamura, S.\u00a0Ohga, A.\u00a0Yorozu, S.\u00a0Saito, T.\u00a0Kikuchi, T.\u00a0Dokiya, M.\u00a0Fukushima and H.\u00a0Yamanaka declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}